Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenda Amaral

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Plos One|April 8, 2020
Acute inhibition of the CNS-specific kinase TTBK1 significantly lowers tau phosphorylation at several disease relevant sitesGregory M Dillon, Jaclyn L Henderson, Channa Bao, et al.
The Prostate|October 15, 2023
Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJRaphaela Dos Santos Menezes, Maria Cristina Dornas, Carlos Frederico Ferreira Campos, et al.
ACS Chemical Neuroscience|February 22, 2023
Elucidation of the GSK3α Structure Informs the Design of Novel, Paralog-Selective InhibitorsBrenda Amaral, Andrew Capacci, Trip Anderson, et al.
Journal of Medicinal Chemistry|May 4, 2021
Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In VivoTamara Halkina, Jaclyn L Henderson, Edward Y Lin, et al.
Journal of Medicinal Chemistry|September 20, 2019
Structural Basis for Achieving GSK-3β Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug DiscoveryVadim Bernard-Gauthier, Andrew V Mossine, Ashley Knight, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Plos One|April 8, 2020
Acute inhibition of the CNS-specific kinase TTBK1 significantly lowers tau phosphorylation at several disease relevant sitesGregory M Dillon, Jaclyn L Henderson, Channa Bao, et al.
The Prostate|October 15, 2023
Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJRaphaela Dos Santos Menezes, Maria Cristina Dornas, Carlos Frederico Ferreira Campos, et al.
ACS Chemical Neuroscience|February 22, 2023
Elucidation of the GSK3α Structure Informs the Design of Novel, Paralog-Selective InhibitorsBrenda Amaral, Andrew Capacci, Trip Anderson, et al.
Journal of Medicinal Chemistry|May 4, 2021
Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In VivoTamara Halkina, Jaclyn L Henderson, Edward Y Lin, et al.
Journal of Medicinal Chemistry|September 20, 2019
Structural Basis for Achieving GSK-3β Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug DiscoveryVadim Bernard-Gauthier, Andrew V Mossine, Ashley Knight, et al.
Pageof 1